WallStreetZenWallStreetZen

NYSEMKT: VTAK
Catheter Precision Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VTAK past revenue growth

How has VTAK's revenue growth performed historically?
Company
3,057.14%
Industry
9.25%
Market
17.15%
VTAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VTAK's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VTAK's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VTAK earnings and revenue history

Current Revenue
$442.0k
Current Earnings
-$71.4M
Current Profit Margin
-16,147.5%

VTAK Return on Equity

Current Company
-277.9%
Current Industry
10.5%
Current Market
188%
VTAK's Return on Equity (-277.9%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VTAK announces earnings.

VTAK Return on Assets

Current Company
-193.3%
Current Industry
5.3%
VTAK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VTAK Return on Capital Employed

Current Company
-249.69%
Current Industry
8.3%
VTAK's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VTAK vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VTAK$442.00k-$68.50M-$71.37M-41.14%N/A
INVO$3.02M-$6.88M-$8.03M+43.62%N/A
AEMD$574.25k-$11.89M-$12.25M+20.67%N/A
RSLS$8.68M-$11.21M-$11.39M-0.95%N/A
TNON$2.93M-$15.13M-$15.58M+403.75%N/A
View Top Medical Device Stocks

VTAK earnings dates

Next earnings date
May 31, 2024

Catheter Precision Earnings & Revenue FAQ

What were VTAK's earnings last quarter?

On Invalid Date, Catheter Precision (NYSEMKT: VTAK) reported Q4 2023 earnings per share (EPS) of $1.21, up 40.1% year over year. Total Catheter Precision earnings for the quarter were -$669.00 thousand. In the same quarter last year, Catheter Precision's earnings per share (EPS) was $2.02.

If you're new to stock investing, here's how to buy Catheter Precision stock.

What was VTAK's earnings growth in the past year?

As of Q2 2024, Catheter Precision's earnings has grown year over year. Catheter Precision's earnings in the past year totalled -$71.37 million.

What is VTAK's earnings date?

Catheter Precision's earnings date is Invalid Date. Add VTAK to your watchlist to be reminded of VTAK's next earnings announcement.

What was VTAK's revenue last quarter?

On Invalid Date, Catheter Precision (NYSEMKT: VTAK) reported Q4 2023 revenue of $128.00 thousand up Infinity% year over year. In the same quarter last year, Catheter Precision's revenue was $0.00.

What was VTAK's revenue growth in the past year?

As of Q2 2024, Catheter Precision's revenue has grown 3,057.14% year over year. This is 3,047.89 percentage points higher than the US Medical Devices industry revenue growth rate of 9.25%. Catheter Precision's revenue in the past year totalled $442.00 thousand.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.